Viridian Therapeutics, Inc. (VRDN)

NASDAQ: VRDN · Real-Time Price · USD

24.02

-0.27 (-1.11%)

At close: Aug 24, 2026, 4:00 PM EDT

23.78

-0.24 (-1.00%)

After-hours: Aug 24, 2026, 7:40 PM EDT

Viridian Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	71.13	70.85	0.3	0.31	1.77	2.96
Revenue Growth	23220.33%	23359.93%	-3.82%	-82.28%	-40.20%	182.19%
Cost of Revenue	324.68	338.93	238.25	159.77	100.89	56.89
Gross Profit	-253.55	-268.08	-237.95	-159.45	-99.12	-53.92
Selling, General & Admin	151.65	95.32	61.08	95	35.18	25.81
Operating Expenses	151.65	95.32	61.08	95	35.18	25.81
Operating Income	-405.2	-363.4	-299.04	-254.45	-134.3	-79.73
Interest Expense	-15.62	-4.95	-2.2	-1.33	-0.49	-0
Interest & Investment Income	29.68	27.4	31.6	18.24	4.92	0.32
Other Non Operating Income (Expenses)	4.17	-1.66	-0.31	-0.19	-	-
EBT Excluding Unusual Items	-386.97	-342.6	-269.95	-237.73	-129.87	-79.41
Pretax Income	-386.97	-342.6	-269.95	-237.73	-129.87	-79.41
Net Income	-386.97	-342.6	-269.95	-237.73	-129.87	-79.41
Preferred Dividends & Other Adjustments	-52.94	-60.67	-61.39	-62.73	-42.83	-
Net Income to Common	-334.03	-281.93	-208.56	-175.01	-87.04	-79.41
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	97	85	68	45	32	12
Shares Outstanding (Diluted)	97	85	68	45	32	12
Shares Change	24.83%	24.92%	51.68%	39.48%	169.22%	235.07%
EPS (Basic)	-3.46	-3.32	-3.07	-3.91	-2.71	-6.66
EPS (Diluted)	-3.46	-3.32	-3.07	-3.91	-2.71	-6.66
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-335.04	-276.89	-232.83	-185.07	-94.64	-54.92
Free Cash Flow Per Share	-3.47	-3.27	-3.43	-4.13	-2.95	-4.61
Operating Margin	-569.68%	-512.91%	-99018.21%	-81035.03%	-7579.23%	-2690.79%
Profit Margin	-469.63%	-397.93%	-69059.60%	-55734.71%	-4912.13%	-2680.15%
Free Cash Flow Margin	-471.04%	-390.81%	-77096.03%	-58938.85%	-5340.58%	-1853.49%
EBITDA	-404.73	-362.94	-298.5	-253.93	-134.05	-79.61
D&A For EBITDA	0.47	0.46	0.54	0.52	0.26	0.12
EBIT	-405.2	-363.4	-299.04	-254.45	-134.3	-79.73
Revenue as Reported	71.13	70.85	0.3	0.31	-	-

SEC Filings: 10-K · 10-Q